Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's disease

F Elifani, E Amico, G Pepe, L Capocci, S Castaldo, P Rosa, E Montano, A Pollice, M Madonna, S Filosa, A Calogero, V Maglione, S Crispi, A Di Pardo

Research output: Contribution to journalArticlepeer-review


Huntington's disease (HD) has traditionally been described as a disorder purely of the brain, however evidence indicates that peripheral abnormalities are also commonly seen. Among others, severe unintended body weight loss represents a prevalent and often debilitating feature of HD pathology, with no therapies available. It correlates with disease progression and significantly affects the quality of life of HD patients. Curcumin, a naturally occurring polyphenol with multiple therapeutic properties, has been validated to exert important beneficial effects under health conditions as well as in different pathological settings, including neurodegenerative and gastrointestinal (GI) disorders. Here, we investigated the potential therapeutic action that curcumin-supplemented diet may exert on central and peripheral dysfunctions in R6/2 mice, a well-characterized HD animal model which recapitulates some features of human pathology. Maintenance of normal motor function, protection from neuropathology and from GI dysfunction, preservation of GI emptying, and conserved intestinal contractility, proved the beneficial role of life-long dietary curcumin in HD and corroborated the potential of the compound to be exploited to alleviate very debilitating symptoms associated with the disease.

Original languageEnglish
JournalHuman Molecular Genetics
Publication statusE-pub ahead of print - Oct 20 2019


Dive into the research topics of 'Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's disease'. Together they form a unique fingerprint.

Cite this